bioRxivMicrobiology
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
S. Tsujino, S. Deguchi, T. Nomai, M. Padilla-Blanco, A. Plianchaisuk, L. Wang, M. M. Begum, K. Uriu, K. Mizuma, N. Nao, I. Kojima, T. Tsubo, J. Li, Y. Matsumura, M. Nagao, Y. Oda, M. Tsuda, Y. Anraku, S. Kita, H. Yajima, K. Tabata, Z. Guo, A. A. Hinay, K. Yoshimatsu, Y. Yamamoto, , Za
Abstract
In middle-late 2023, a sublineage of SARS-CoV-2 Omicron XBB, EG.5.1 (a progeny of XBB.1.9.2), is spreading rapidly around the world. Here, we performed multiscale investigations to reveal virological features of newly emerging EG.5.1 variant. Our phylogenetic-epidemic dynamics modeling suggested that two hallmark substitutions of EG.5.1, S:F456L and ORF9b:I5T, are critical to the increased viral fitness. Experimental investigations addressing the growth kinetics, sensitivity to clinically available antivirals, fusogenicity and pathogenicity of EG.5.1 suggested that the virological features of EG.5.1 is comparable to that of XBB.1.5. However, the cryo-electron microscopy reveals the structural difference between the spike proteins of EG.5.1 and XBB.1.5. We further assessed the impact of ORF9b:I5T on viral features, but it was almost negligible at least in our experimental setup. Our multiscale investigations provide the knowledge for understanding of the evolution trait of newly emerging pathogenic viruses in the human population.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of an EG.5.1 clinical isolate in vitro and in vivo
R. Uraki, M. Kiso, … Y. Kawaoka·bioRxiv·Aug 31, 2023
- Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against Omicron subvariants including EG.5
- Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
T. Tamura, T. Irie, … T. Fukuhara·bioRxiv·Aug 16, 2023
- Virological characteristics of the SARS-CoV-2 Omicron HK.3 variant harboring the "FLip" substitution
Y. Kosugi, A. Plianchaisuk, … K. Sato·bioRxiv·Nov 14, 2023
- Increased pathogenicity and transmission of SARS-CoV-2 Omicron XBB.1.9 sublineage, including HK.3 and EG.5.1
Qiushi Jin, Ruixue Liu, … Yuwei Gao·Journal of VirologyPeer-reviewed·Nov 18, 2025
- Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
D. Planas, I. Staropoli, … O. Schwartz·bioRxiv·Nov 20, 2023